Cargando…

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Treatment of dyslipidemia patients with lipid-lowering drugs leads to a significant reduction in low-density lipoproteins (LDL) level and a low to moderate level of increase in high-density lipoprotein (HDL) cholesterol in plasma. However, a possible role of these drugs in altering morphology and di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madasamy, Shanmugavel, Liu, David, Lundry, Jason, Alderete, Benjamin, Kong, Raymond, Robinson, J. Paul, Wu, Alan H.B., Amento, Edward P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755343/ https://www.ncbi.nlm.nih.gov/pubmed/29155776 http://dx.doi.org/10.3791/56596

Ejemplares similares

Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
por: Chen, Yundi, et al.
Publicado: (2022)

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
por: Mietus-Snyder, Michele, et al.
Publicado: (2022)

Gypenosides Prevent and Dissolve Cholesterol Gallstones by Modulating the Homeostasis of Cholesterol and Bile Acids
por: Zhuang, Qian, et al.
Publicado: (2022)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Potential lipid-lowering effects of Ulmus macrocarpa Hance extract in adults with untreated high low-density lipoprotein cholesterol concentrations: A randomized double-blind placebo-controlled trial
por: Lee, Ye Li, et al.
Publicado: (2022)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Positive allosteric modulation of the adenosine A(2a) receptor attenuates inflammation
por: Welihinda, Ajith A, et al.
Publicado: (2014)

Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study
por: Wang, Zhaolun, et al.
Publicado: (2022)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

Current evidence on the role of lipid lowering drugs in the treatment of psoriasis
por: Wang, Jiao, et al.
Publicado: (2022)

A blood-mimicking fluid with cholesterol as scatter particles for wall-less carotid artery phantom applications
por: Dakok, Kyermang Kyense, et al.
Publicado: (2021)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Effect of Cholesterol on the Structure and Composition of Glyco-DIBMA Lipid Particles
por: Lenz, Julia, et al.
Publicado: (2023)

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
por: Kasmas, S.H., et al.
Publicado: (2012)

Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis
por: Chidambaram, Vignesh, et al.
Publicado: (2022)

Lowering Cholesterol
por: Lewis, R R, et al.
Publicado: (1999)

Lowering Cholesterol
por: Dudley, Nigel
Publicado: (1999)

Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population
por: Liu, Bo, et al.
Publicado: (2022)

Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review
por: Gianazza, Erica, et al.
Publicado: (2023)

Morphologic variants of Meibomian glands: age-wise distribution and differences between upper and lower eyelids
por: Srivastav, Saumya, et al.
Publicado: (2023)

Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study
por: Kuo, Tzu-Tsen, et al.
Publicado: (2020)

Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults
por: Zhou, Liyuan, et al.
Publicado: (2022)

Lipids and cholesterol
por: Mach, François
Publicado: (2023)

Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis
por: Lou, Chen, et al.
Publicado: (2023)

Cholesterol-lowering Effect of Rice Protein by Enhancing Fecal Excretion of Lipids in Rats
por: Um, Min Young, et al.
Publicado: (2013)

The cholesterol-lowering effects of oat varieties based on their difference in the composition of proteins and lipids
por: Guo, Lina, et al.
Publicado: (2014)

Case report: Strong low-density-cholesterol reduction accompanied by shrinkage of low-attenuation coronary plaque during lipid-lowering treatment with bempedoic acid—serial evaluation by coronary computed tomography angiography
por: Korosoglou, Grigorios, et al.
Publicado: (2023)

US Trends in Cholesterol Screening, Lipid Levels, and Lipid‐Lowering Medication Use in US Adults, 1999 to 2018
por: Gao, Yumin, et al.
Publicado: (2023)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
por: Abdalwahab, Ahmed, et al.
Publicado: (2021)

Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
por: Hoenig, Michel R
Publicado: (2008)

The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies
por: Stellaard, Frans, et al.
Publicado: (2017)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Association of Carotid Plaque Morphology and Glycemic and Lipid Parameters in the Northern Manhattan Study
por: Della-Morte, David, et al.
Publicado: (2022)

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro
por: Chyu, Kuang-Yuh, et al.
Publicado: (2014)

African Nutmeg (Monodora Myristica) Lowers Cholesterol and Modulates Lipid Peroxidation in Experimentally Induced Hypercholesterolemic Male Wistar Rats
por: Onyenibe, Nwozo Sarah, et al.
Publicado: (2015)

Rosmarinic Acid Exhibits a Lipid-Lowering Effect by Modulating the Expression of Reverse Cholesterol Transporters and Lipid Metabolism in High-Fat Diet-Fed Mice
por: Nyandwi, Jean Baptiste, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6d341tl9c5vknvsnjpqrevbonl